Cytokinetics, Incorporated is a biopharmaceutical company focused on developing treatments for diseases related to cardiac muscle dysfunction. The company advances a pipeline of potential medicines, particularly targeting heart failure and hypertrophic cardiomyopathy. Its operations include research and development of therapies aimed at improving patient outcomes in the cardiovascular sector, primarily serving patients in the United States and Europe.
